GSA Capital Partners’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
GIM
PAI
TCM
GSA Capital Partners's BLUE Position: Q1 2024 in Review
GSA Capital Partners sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 1,063 shares — an estimated $29K sold.
GSA Capital Partners first reported a position in BLUE in Q3 2014 and held it in 15 quarters. The position peaked at $5.7M in Q2 2015. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.
- GSA Capital Partners reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
- GSA Capital Partners sold 1,063 bluebird bio shares in Q1 2024, an estimated $29K.
- GSA Capital Partners first reported a position in bluebird bio in Q3 2014 and held it in 15 quarters.
- GSA Capital Partners's bluebird bio position peaked at $5.7M in Q2 2015.
- 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.
Based on GSA Capital Partners's 13F filing for Q1 2024, filed 3 May 2024.